Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Name: Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
License: Public Domain

Dipenkumar Modi

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

large cell lymphoma, diffuse, relapsed cancer, refractory cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 474746
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.